Taiho’s Oral, Mutation-Agnostic DMD Candidate Misses Phase III Endpoint

Japan-Only Trial

 
• By Lisa Takagi
  
DMD p3 in Japan
Japan Phase III miss for Taisho's DMD candidate but multiple others in development in country (Shutterstock)
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Clinical Trials

More from Japan